CCP208: On GLP-1s

In this week's conversation between Dr. James Emery White and co-host Alexis Drye, they discuss one of the most dominant cultural medical news stories over the last several months - GLP-1 weight-loss drugs. In the U.S., 42% of adults and nearly 20% of children are clinically obese. And if you incorporate factors such as waist measurement and fat distribution, then the rates of obesity go up even higher. Being overweight is linked to more than 40 chronic conditions including diabetes, heart disease, stroke and various cancers. So how are we to consider the impact of these drugs from a Christian worldview?

Episode Links

As Dr. White mentioned, here are the links to a number of articles that are related to today's conversation that we suggest you take a moment to read:

Christopher Rowland, “Americans are taking GLP-1 drugs in record numbers,” The Washington Post.

Ariana Eunjung Cha and Aaron Steckelberg, “13 surprising ways GLP-1s may benefit the body, according to science,” The Washington Post.

Christopher Rowland, “3 ways GLP-1 drugs could be getting better,” The Washington Post.

Kelsey Kramer McGinnis, “Christians Debate Drugs vs. Discipline in the Age of Ozempic,” Christianity Today.

Shelby Grad, “Why we've become so suspicious of people who lose weight. John Goodman's trending moment,” Los Angeles Times.

For those of you who are new to Church & Culture, we'd love to invite you to subscribe (for free of course) to the Church & Culture blog and check out the Daily Headline News - a collection of headlines from around the globe each weekday. We'd also love to hear from you if there is a topic that you'd like to see discussed on the Church & Culture Podcast in an upcoming episode. You can find the form to submit your questions at the bottom of the podcast page HERE.